TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jon Woodward
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Quantum BioPharma is highlighting a three-part investigative series about alleged stock market manipulation through 'stock spoofing', involving a $700 million lawsuit against CIBC and RBC banks, focusing on their multiple sclerosis research drug Lucid-MS.

Insights
JPMpL   neutral

Serving as a joint book-running manager for the IPO, performing a standard financial service role


QNTM   neutral

Company is proactively addressing potential market manipulation and seeking legal recourse while maintaining focus on their research